These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8323179)
1. Therapeutic use of gonadotropin-releasing hormone agonists in polycystic ovarian syndrome. Markussis V; Goni MH; Tolis G Ann N Y Acad Sci; 1993 May; 687():242-9. PubMed ID: 8323179 [TBL] [Abstract][Full Text] [Related]
2. Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Yen SS Fertil Steril; 1983 Mar; 39(3):257-66. PubMed ID: 6130985 [TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511 [TBL] [Abstract][Full Text] [Related]
4. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501 [TBL] [Abstract][Full Text] [Related]
5. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835 [TBL] [Abstract][Full Text] [Related]
6. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment. Cheung AP; Lu JK; Chang RJ Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone. Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389 [TBL] [Abstract][Full Text] [Related]
8. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. Steingold K; De Ziegler D; Cedars M; Meldrum DR; Lu JK; Judd HL; Chang RJ J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031 [TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass. Lupoli G; Di Carlo C; Nuzzo V; Vitale G; Russo D; Palomba S; Nappi C J Endocrinol Invest; 1997 Sep; 20(8):493-6. PubMed ID: 9364254 [TBL] [Abstract][Full Text] [Related]
10. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients. Hosseini MA; Aleyasin A; Saeedi H; Mahdavi A J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044 [TBL] [Abstract][Full Text] [Related]
12. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma. Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963 [TBL] [Abstract][Full Text] [Related]
13. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Gonzalez F; Hatala DA; Speroff L Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519 [TBL] [Abstract][Full Text] [Related]
14. Sonographic monitoring of ovarian volume during LHRH analogue therapy in women with polycystic ovarian syndrome. Jaffe R; Abramowicz J; Eckstein N; Vagman I; Fejgin M; Ayalon D J Ultrasound Med; 1988 Apr; 7(4):203-6. PubMed ID: 2966864 [TBL] [Abstract][Full Text] [Related]
15. Effects of gonadotropin-releasing hormone agonist and antagonist on ovarian activity in a mouse model for polycystic ovary. Singh P; Srivastava RK; Krishna A J Steroid Biochem Mol Biol; 2016 Oct; 163():35-44. PubMed ID: 27036999 [TBL] [Abstract][Full Text] [Related]